Preferred Name |
aliskiren |
|
Synonyms |
2(S),4(S),5(S),7(S)-N-(2-carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-(4-methoxy-3-(3-methoxypropoxy)phenyl)octanamid hemifumarate |
|
ID |
http://purl.bioontology.org/ontology/MESH/C446481 |
|
altLabel |
2(S),4(S),5(S),7(S)-N-(2-carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-(4-methoxy-3-(3-methoxypropoxy)phenyl)octanamid hemifumarate CGP 060536B Tekturna CGP060536B CGP-060536B SPP100 rasilez |
|
cui |
C1122704 C2001247 C1120110 C3852760 C1870961 C1120111 |
|
HM |
D005650 D000577 |
|
II |
D012083/Q000037 D000959 |
|
Inverse of RB |
502FWN4Q32 C8A0P8G029 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20140811 |
|
MeSH Frequency |
955 |
|
MMR |
20230627 |
|
notation |
C446481 |
|
PA |
D000092502 |
|
prefLabel |
aliskiren |
|
RR |
C8A0P8G029 |
|
SC |
1 |
|
Scope Statement |
orally active nonpeptidic renin inhibitor |
|
SRC |
Hypertension 2002 Jan;39(1):E1-8 |
|
TERMUI |
T481628 T481626 T709510 T709512 T000864239 T688464 T481627 T709511 |
|
TH |
NLM (2002) FDA SRS (2013) USAN (19XX) INN (19XX) NLM (2006) NLM (2007) NLM (2014) |
|
tui |
T109 T121 |